Lotemax
Brand names,
Lotemax
Analogs
Lotemax
Brand Names Mixture
Lotemax
Chemical_Formula
C19H32N2O5
Lotemax
RX_link
http://www.rxlist.com/cgi/generic/aceon.htm
Lotemax
fda sheet
Lotemax
msds (material safety sheet)
Lotemax
Synthesis Reference
No information avaliable
Lotemax
Molecular Weight
368.468 g/mol
Lotemax
Melting Point
No information avaliable
Lotemax
H2O Solubility
No information avaliable
Lotemax
State
No information avaliable
Lotemax
LogP
2.633
Lotemax
Dosage Forms
Tablet
Lotemax
Indication
Used in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction.
Lotemax
Pharmacology
Perindopril is indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. It can be used with conventional treatment for management of coronary artery disease, such as antiplatelet, antihypertensive or lipid-lowering therapy. It is also indicated for the treatment of patients with essential hypertension. Perindopril belongs to a group of medicines called ACE inhibitors which block the action of a chemical in the body called angiotensin converting enzyme (ACE). Normally ACE produces another chemical, angiotensin. Thus perindopril reduces the amount of angiotensin in the blood. Angiotensin has two actions. Firstly it acts on blood vessels to make them narrow and secondly it acts on the kidney to produce less urine. As perindopril stops the production of angiotensin, these actions are reversed. Therefore more urine is produced by the kidneys, which results in less fluid in the blood vessels. The blood vessels also widen. The overall effect of this is a drop in blood pressure and a decrease in the workload of the heart.
Lotemax
Absorption
Rapid
Lotemax
side effects and Toxicity
No information avaliable
Lotemax
Patient Information
No information avaliable
Lotemax
Organisms Affected
Humans and other mammals